Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Glucagon‑like peptide‑1 (GLP‑1) receptor agonists have revolutionized type 2 diabetes and obesity treatment—but could they also impact your brain? As headlines tout possible cognitive benefits, many patients and clinicians are asking: Can GLP‑1 drugs lower dementia risk? This article breaks down what we know so far, explains the science behind …
Read More »GLP‑1s and Dementia: Sorting Hype from Hope in Brain Health Research
